ISSN 1301-109X | e-ISSN 2147-8325
The CpG Island Methylation Status and mRNA Expression Level of <i>CTLA4</i> in Childhood Hashimoto’s Thyroiditis [Turk J Immunol]
Turk J Immunol. 2023; 11(1): 17-22 | DOI: 10.4274/tji.galenos.2023.70883

The CpG Island Methylation Status and mRNA Expression Level of CTLA4 in Childhood Hashimoto’s Thyroiditis

Fatemeh Saffari1, Mohammad Hossein Ahmadi2, Mehdi Azad2, Neda Karami3, Amirhosein Maali4, Neda Mohammadi5, Ali Homaei6, Farshad Foroughi7
1Department of Pediatrics, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran, Children Growth Research Center, Qazvin University of Medical Sciences, Qazvin, Iran and Research Institute for prevention of Non-communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
2Department of Medical Laboratory Sciences, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
3Department of Medical Biotechnology, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
4Department of Medical Biotechnology, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran and Department of Immunology, Pasteur Institute of Iran, Tehran, Iran
5Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
6Department of Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7Department of Immunology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran and Cellular and Molecular Research Center, Research Institute for Prevention of non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran

Objective: Hashimoto’s thyroiditis (HT) is an autoimmune thyroid disease characterized by thyroid-specific autoantibodies. Recent studies have shown the critical footprint of DNA methylation in autoimmune diseases. The aberrant DNA methylation of CTLA4 has been previously reported in autoimmune thyroid diseases. This study aimed to investigate the methylation status of the CpG island of CTLA4 promoter and its mRNA expression level in HT patients.
Materials and Methods: In this case-control study, 45 HT patients (admitted to Qods Hospital, Qazvin, Iran) and 5 healthy individuals participated. After RNA and DNA extractions, the DNA methylation pattern of the CpG island of CTLA4 promoter and CTLA4 mRNA expression level were evaluated. All statistical analyses were performed using SPSS ver 20.
Results: Our results indicated partial hypermethylation status in the CpG island of CTLA4 promoter in HT patients compared to normal individuals, but this hypermethylation was not significantly higher (p=0.332). The mRNA expression level of CTLA4 was significantly decreased in HT patients compared to that of controls (Foldchange=0.31, p=0.015). Also, serum level of anti-TPO antibody was not significantly correlated with CTLA4 expression level and its methylation status.
Conclusion: Since the CTLA4 acts as an immune checkpoint that leads to the downregulation of immune response, partial hypermethylation and downregulation of CTLA4 may play a critical role in preventing switching off the immune response after a hyperactivation against the thyroid.

Keywords: Autoimmune diseases, Hashimoto disease, CTLA4, DNA methylation, gene expression

Corresponding Author: Farshad Foroughi, Iran
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE
LookUs & Online Makale